The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

As per The Business Research Company’s Anti-Inflammatory Therapeutics Global Market Report 2023, the anti-inflammatory therapeutics market is expected to show significant growth in the forecast period.

Steady Growth Trajectory
The anti-inflammatory therapeutics market has witnessed a steady ascent in recent years, progressing from $109.88 billion in 2023 to $114.71 billion in 2024, reflecting a Compound Annual Growth Rate (CAGR) of 4.4%. This growth in the historic period can be attributed to several factors, including the prevalence of chronic diseases, an aging population, increased awareness, and government initiatives.

Future Projections
The market is poised for continuous growth, with a forecasted size of $135.6 billion in 2028, boasting a CAGR of 4.3%. Anticipated factors driving this growth include innovative therapies, increasing healthcare expenditure, focus on rare diseases, and the prominence of biologics and biosimilars. Major trends in the forecast period encompass advancements in immunotherapy, integration of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the expansion of indications.

Challenges: Increasing Side Effects
However, the growth of the anti-inflammatory therapeutics market faces a challenge posed by the increasing side effects of drugs. Medications like ibuprofen, part of anti-inflammatory therapeutics, may induce side effects due to the complexity of inflammatory signaling pathways. Reports from August 2022 highlight that 4% to 16% of participants using ibuprofen tablets experienced at least one gastrointestinal side effect, presenting a potential constraint for the market.

Key Players in the Industry
Major players contributing to the vibrancy of the anti-inflammatory therapeutics market include Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., and many others. This diverse array of companies ensures a competitive landscape and continual innovation.

View More On The Anti-Inflammatory Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Innovation Strengthens Market Position
Innovation emerges as a cornerstone in the market, with major companies introducing groundbreaking drugs to fortify their market positions. A notable example is the launch of Kevzara (sarilumab) by Regeneron Pharmaceuticals Inc. and Sanofi. Positioned as the first anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatic (PMR), Kevzara addresses an unmet medical need, showcasing the industry’s commitment to innovation.

Strategic Acquisition Fuels Expansion
Strategic acquisitions further shape the industry landscape. Pfizer Inc.’s acquisition of Arena Pharmaceuticals for $6.7 billion in March 2022 exemplifies this trend. The move aims to expand Pfizer’s inflammation and immunology therapeutics portfolio, encompassing conditions such as ulcerative colitis, Crohn’s disease, atopic dermatitis, eosinophilic esophagitis, and alopecia areata.

Market Segmentation
The anti-inflammatory therapeutics market is segmented based on crucial parameters:

• Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
• Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
• Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Regional Dynamics
In 2023, North America stood as the largest region in the anti-inflammatory therapeutics market. Looking forward, Europe is anticipated to be the fastest-growing region in the forecast period, underlining the global nature of the market’s expansion.

Request A Sample Of The Global Anti-Inflammatory Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=12861&type=smp

The Anti-Inflammatory Therapeutics Global Market Report 2023  provides an in-depth analysis on the anti-inflammatory therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the anti-inflammatory therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Non-Steroidal Anti-Inflammatory Drugs Global Market Report 2023
Peptide Therapeutics Global Market Report 2023
Inflammatory Bowel Disease Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model